Platelet-Derived Growth Factor D Induces Cardiac Fibrosis and Proliferation of Vascular Smooth Muscle Cells in Heart-Specific Transgenic Mice

Platelet-derived growth factor (PDGF)-D is a member of the PDGF/vascular endothelial growth factor family that activates PDGF receptor β (PDGFR-β). We show that PDGF-D is highly expressed in the myocardium throughout development and adulthood, as well as by arterial vascular smooth muscle cells (vSMCs). To obtain further knowledge regarding the in vivo response to PDGF-D, we generated transgenic mice overexpressing the active core domain of PDGF-D in the heart. Transgenic PDGF-D stimulates proliferation of cardiac interstitial fibroblasts and arterial vSMCs. This results in cardiac fibrosis followed by dilated cardiomyopathy and subsequent cardiac failure. Transgenic mice also display vascular remodeling, including dilation of vessels, increased density of SMC-coated vessels, and proliferation of vSMCs, leading to a thickening of tunica media. The thickening of arterial walls is a unique feature of PDGF-D, because this is not seen when PDGF-C is overexpressed in the heart. These results show that PDGF-D, via PDGFR-β signaling, is a potent modulator of both vascular and connective tissue growth and may provide both paracrine and autocrine stimulation of PDGFR-β. Our data raise the possibility that this growth factor may be involved in cardiac fibrosis and atherosclerosis.

[1]  H. Kim,et al.  Platelet-Derived Growth Factor D Is Activated by Urokinase Plasminogen Activator in Prostate Carcinoma Cells , 2005, Molecular and Cellular Biology.

[2]  Y. Zhen,et al.  PDGF-D contributes to neointimal hyperplasia in rat model of vessel injury. , 2005, Biochemical and biophysical research communications.

[3]  K. Alitalo,et al.  PDGF-D induces macrophage recruitment, increased interstitial pressure, and blood vessel maturation during angiogenesis. , 2004, Blood.

[4]  C. Fieber,et al.  Tissue plasminogen activator is a potent activator of PDGF‐CC , 2004, The EMBO journal.

[5]  D. Dichek,et al.  Overexpression of Urokinase by Macrophages or Deficiency of Plasminogen Activator Inhibitor Type 1 Causes Cardiac Fibrosis in Mice , 2004, Circulation research.

[6]  C. Betsholtz,et al.  A specific requirement for PDGF-C in palate formation and PDGFR-α signaling , 2004, Nature Genetics.

[7]  E. Raines PDGF and cardiovascular disease. , 2004, Cytokine & growth factor reviews.

[8]  C. Betsholtz Insight into the physiological functions of PDGF through genetic studies in mice. , 2004, Cytokine & growth factor reviews.

[9]  J. Bonner,et al.  Regulation of PDGF and its receptors in fibrotic diseases. , 2004, Cytokine & growth factor reviews.

[10]  J. Hoover-Plow,et al.  The functions of plasminogen in cardiovascular disease. , 2004, Trends in cardiovascular medicine.

[11]  D. Dichek,et al.  Macrophage-Targeted Overexpression of Urokinase Causes Accelerated Atherosclerosis, Coronary Artery Occlusions, and Premature Death , 2004, Circulation.

[12]  C. Alpers,et al.  J Am Soc Nephrol 15: 286–298, 2004 Exogenous PDGF-D Is a Potent Mesangial Cell Mitogen and Causes a , 2022 .

[13]  T. Sjöblom,et al.  Transgenic overexpression of platelet-derived growth factor-C in the mouse heart induces cardiac fibrosis, hypertrophy, and dilated cardiomyopathy. , 2003, The American journal of pathology.

[14]  A. Cho,et al.  Matrix Metalloproteinase-9 Is Necessary for the Regulation of Smooth Muscle Cell Replication and Migration After Arterial Injury , 2002, Circulation research.

[15]  A. Hamsten,et al.  Differential expression of cysteine and aspartic proteases during progression of atherosclerosis in apolipoprotein E-deficient mice. , 2002, The American journal of pathology.

[16]  M. Moore,et al.  Platelet-derived Growth Factor C (PDGF-C), a Novel Growth Factor That Binds to PDGF α and β Receptor* , 2001, The Journal of Biological Chemistry.

[17]  K. Alitalo,et al.  Chromosomal Location, Exon Structure, and Vascular Expression Patterns of the Human PDGFC and PDGFD Genes , 2001, Circulation.

[18]  C. Heldin,et al.  PDGF-D is a specific, protease-activated ligand for the PDGF β-receptor , 2001, Nature Cell Biology.

[19]  J. Rothberg,et al.  PDGF-D, a new protease-activated growth factor , 2001, Nature Cell Biology.

[20]  R. Fandrich,et al.  Overexpression of FGF-2 increases cardiac myocyte viability after injury in isolated mouse hearts. , 2001, American journal of physiology. Heart and circulatory physiology.

[21]  N. Samani,et al.  Expression of the plasminogen activator system in the human vascular wall. , 2000, Atherosclerosis.

[22]  C. Heldin,et al.  PDGF-C is a new protease-activated ligand for the PDGF α-receptor , 2000, Nature Cell Biology.

[23]  L. Field,et al.  Atrial but not ventricular fibrosis in mice expressing a mutant transforming growth factor-beta(1) transgene in the heart. , 2000, Circulation research.

[24]  L. Powell-Braxton,et al.  Hypertension and endothelial dysfunction in apolipoprotein E knockout mice. , 1999, Arteriosclerosis, thrombosis, and vascular biology.

[25]  R. Schwartz,et al.  Local insulin‐like growth factor I expression induces physiologic, then pathologic, cardiac hypertrophy in transgenic mice , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[26]  C. Betsholtz,et al.  Role of PDGF-B and PDGFR-beta in recruitment of vascular smooth muscle cells and pericytes during embryonic blood vessel formation in the mouse. , 1999, Development.

[27]  W. Cavenee,et al.  Induction of vascular endothelial growth factor expression in endothelial cells by platelet-derived growth factor through the activation of phosphatidylinositol 3-kinase. , 1999, Cancer research.

[28]  C. Heldin,et al.  Mechanism of action and in vivo role of platelet-derived growth factor. , 1999, Physiological reviews.

[29]  A. Demetris,et al.  Cardiac-specific overexpression of tumor necrosis factor-alpha causes lethal myocarditis in transgenic mice. , 1997, Journal of cardiac failure.

[30]  J. Robbins,et al.  Tissue-specific regulation of the alpha-myosin heavy chain gene promoter in transgenic mice. , 1991, The Journal of biological chemistry.

[31]  Kenneth W. Watson,et al.  A Decade of Progress , 1972, Journal of The Royal Naval Medical Service.

[32]  P. Carmeliet,et al.  Loss or inhibition of uPA or MMP-9 attenuates LV remodeling and dysfunction after acute pressure overload in mice. , 2005, The American journal of pathology.

[33]  I. Komuro,et al.  Gene Expression in Fibroblasts and Fibrosis: Involvement in Cardiac Hypertrophy Roles of Cardiac Transcription Factors in Cardiac Hypertrophy Ras, Akt, and Mechanotransduction in the Cardiac Myocyte G Protein–Coupled Signaling and Gene Expression Genetic Models and Mechanisms of Transcription in Car , 2003 .

[34]  Dian Feng,et al.  Heterogeneity of the Angiogenic Response Induced in Different Normal Adult Tissues by Vascular Permeability Factor/Vascular Endothelial Growth Factor , 2000, Laboratory Investigation.